Modèle de régression optimale des traits de conformation et de la production laitière des troupeaux bovins de race kouri élevés à la station de Sayam du Niger.

Objectif : évaluer en station, la pertinence des traits de conformation traditionnellement privilégiés par les éleveurs kouri, pour l’identification des meilleures vaches laitières.Méthodologie et résultats : La production laitière et treize traits biométriques ont été évalués sur 54 vaches, de septembre 2015 à février 2016, au Centre de Multiplication de Bétail de Sayam, après six (6) mois de contrôle laitier. Il est constaté que la production laitière journalière était positivement corrélée aux traits de conformation du bassin (largeur aux ischions (r = 0.35**) et la largeur aux trochanters (r = 0.36**)), à la profondeur de poitrine (r = 0.27*), à la largeur aux poitrines (r = 0.29*) et au rapport de la largeur aux poitrines sur la largeur aux hanches (r = 0.28*). Le modèle de régression optimale de la production laitière qui s’est bien ajusté de façon hautement significative (p = 0.004) est un modèle utilisant la largeur-Trochanters et le rapport largeur- Poitrine/Largeur-hanche comme indices prévisionnels. La valeur du R carrée ajusté du modèle et de l’erreur standard des résidus étaient respectivement 0.16 et 0.43.Conclusion et perspectives : les traits biométriques intéressants, identifiés comme promoteurs dans cette étude, peuvent être inclus dans le développement de mécanismes de sélection qui peut encore être couplé à des techniques modernes de sélection. Le modèle ainsi obtenu, pourrait être utilisé pour prédire la production de lait des vaches kouri ou à des fins de sélection.Mots clés : Corrélation, modélisation, traits de conformation, production laitière, kour

Lymphome Cérébral Primitif (LCP) du Sujet Immunocompétent: A Propos d’Un cas à l’Hôpital National de Niamey (HNN)

Le Lymphome Cérébral Primitif (LCP) du sujet immunocompétent est une entité rare des lymphomes Non Hodgkiniens en général et des tumeurs cérébrales en particulier. Il est caractérisé par sa sévérité clinique, mais aussi son mauvais pronostic. Nous rapportons un cas de LCP chez un sujet immunocompétent diagnostiqué au service de neurologie et pris en charge au service d’Onco-hématologie de l’Hôpital National de Niamey.   Primary Cerebral Lymphoma (PCL) of the immunocompetent subject is a rare feature of non-Hodgkin's lymphoma in general and brain tumors in particular. It is characterized by its clinical severity, but also its poor prognosis. We report a case of LCP in an immunocompetent subject diagnosed in the neurology department and managed by Onco-hematology at the National Hospital of Niamey

Lymphome Cérébral Primitif (LCP) du Sujet Immunocompétent: A Propos d’Un cas à l’Hôpital National de Niamey (HNN)

Le Lymphome Cérébral Primitif (LCP) du sujet immunocompétent est une entité rare des lymphomes Non Hodgkiniens en général et des tumeurs cérébrales en particulier. Il est caractérisé par sa sévérité clinique, mais aussi son mauvais pronostic. Nous rapportons un cas de LCP chez un sujet immunocompétent diagnostiqué au service de neurologie et pris en charge au service d’Onco-hématologie de l’Hôpital National de Niamey.   Primary Cerebral Lymphoma (PCL) of the immunocompetent subject is a rare feature of non-Hodgkin's lymphoma in general and brain tumors in particular. It is characterized by its clinical severity, but also its poor prognosis. We report a case of LCP in an immunocompetent subject diagnosed in the neurology department and managed by Onco-hematology at the National Hospital of Niamey

Interet D’une Supplementation En Spiruline Chez Les Enfants Drepanocytaires Homozygotes A L’hopital National De Niamey. (Essai Clinique Randomise En Double Aveugle A Propos De 53 Cas)

Spirulina is a micro algae used for thousands of years due to its healing properties. We supplemented children suffering from sickle cell anemia in order to appreciate its impact on the anthropometrical and clinical parameters. It consisted of a randomized clinical double blind test which was carried during a period of 9 months. The study concerned 53 homozygotes children suffering from sickle cell anemia aged 6 months to 15 years. Also, they were visiting the National Hospital of Niamey for follow up. One group (28 children) received 5 g of spirulina daily, and the other group (25 children) received placebo. The aspects studied were: the number of hospitalizations and transfusions, the vaso-occlusive crisis, the body mass index, and the splenomegalia. We found that 84.90% of patients were hospitalized at least once and 45.3% of them have already been transfused. The average number of crisis has greatly decreased in the spirulina group from 2.75 before the study to 1.18 at the end of the study. This, thus, was observed when compared to 2.44 to 1.6 in the placebo group. We also noticed a decrease of the number of hospitalizations and the number of transfusions which is less important in the group supplemented with spirulina. In conclusion, this study showed that supplementation in spirulina had a significant impact on children suffering from sickle cell anemia. This is even despite the fact that the difference between the two groups is not significant in some cases

Characterization of 9-Nitrocamptothecin Liposomes: Anticancer Properties and Mechanisms on Hepatocellular Carcinoma In Vitro and In Vivo

BACKGROUND: Hepatocellular carcinoma (HCC) is the third most common cause of cancer related mortality worldwide. 9-Nitrocamptothecin (9NC) is a potent topoisomerase-I inhibitor with strong anticancer effect. To increase the solubility and stability, we synthesized a novel 9NC loaded liposomes (9NC-LP) via incorporating 9NC into liposomes. In the present study, we determined the effects of 9NC and 9NC-LP on in vitro and in vivo, and the underlying mechanisms. METHODOLOGY/PRINCIPAL FINDINGS: We first analyzed the characteristics of 9NC-LP. Then we compared the effects of 9NC and 9NC-LP on the proliferation and apoptosis of HepG2, Bel-7402, Hep3B and L02 cells in vitro. We also investigated their anticancer properties in nude mice bearing HCC xenograft in vivo. 9NC-LP has a uniform size (around 190 nm) and zeta potential (∼-11 mV), and exhibited a steady sustained-release pattern profile in vitro. Both 9NC and 9NC-LP could cause cell cycle arrest and apoptosis in a dose-dependent and p53-dependent manner. However, this effect was not ubiquitous in all cell lines. Exposure to 9NC-LP led to increased expression of p53, p21, p27, Bax, caspase-3, caspase-8, caspase-9 and apoptosis-inducing factor, mitochondrion-associated 1 and decreased expression of Bcl-2, cyclin E, cyclin A, Cdk2 and cyclin D1. Furthermore, 9NC-LP exhibited a more potent antiproliferative effect and less side effects in vivo. Western blot analysis of the xenograft tumors in nude mice showed similar changes in protein expression in vivo. CONCLUSIONS/SIGNIFICANCE: In conclusion, 9NC and 9NC-LP can inhibit HCC growth via cell cycle arrest and induction of apoptosis. 9NC-LP has a more potent anti-tumor effect and fewer side effects in vivo, which means it is a promising reagent for cancer therapy via intravenous administration

P2 receptors in atherosclerosis and postangioplasty restenosis

Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction [Ross (Nature 362:801–09, 1993); Fuster et al. (N Engl J Med 326:242–50, 1992); Davies and Woolf (Br Heart J 69:S3–S11, 1993)]. Extracellular nucleotides that are released from a variety of arterial and blood cells [Di Virgilio and Solini (Br J Pharmacol 135:831–42, 2002)] can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC), which are known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis [Lafont et al. (Circ Res 76:996–002, 1995)]. In addition, P2 receptors mediate many other functions including platelet aggregation, leukocyte adherence, and arterial vasomotricity. A direct pathological role of P2 receptors is reinforced by recent evidence showing that upregulation and activation of P2Y2 receptors in rabbit arteries mediates intimal hyperplasia [Seye et al. (Circulation 106:2720–726, 2002)]. In addition, upregulation of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model [Carpenter et al. (Stroke 32:516–22, 2001)] and in coronary artery of diabetic dyslipidemic pigs [Hill et al. (J Vasc Res 38:432–43, 2001)]. It has been proposed that upregulation of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis [Elmaleh et al. (Proc Natl Acad Sci U S A 95:691–95, 1998)]. Therefore, particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels, which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty

A perspective on SIDS pathogenesis. The hypotheses: plausibility and evidence

Several theories of the underlying mechanisms of Sudden Infant Death Syndrome (SIDS) have been proposed. These theories have born relatively narrow beach-head research programs attracting generous research funding sustained for many years at expense to the public purse. This perspective endeavors to critically examine the evidence and bases of these theories and determine their plausibility; and questions whether or not a safe and reasoned hypothesis lies at their foundation. The Opinion sets specific criteria by asking the following questions: 1. Does the hypothesis take into account the key pathological findings in SIDS? 2. Is the hypothesis congruent with the key epidemiological risk factors? 3. Does it link 1 and 2? Falling short of any one of these answers, by inference, would imply insufficient grounds for a sustainable hypothesis. Some of the hypotheses overlap, for instance, notional respiratory failure may encompass apnea, prone sleep position, and asphyxia which may be seen to be linked to co-sleeping. For the purposes of this paper, each element will be assessed on the above criteria

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

Background Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide.Methods A multimethods analysis was performed as part of the GlobalSurg 3 study-a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital.Findings Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3.85 [95% CI 2.58-5.75]; p<0.0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63.0% vs 82.7%; OR 0.35 [0.23-0.53]; p<0.0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer.Interpretation Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised